Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Biochemistry, University of Oxford, Oxford, UK.
Science. 2022 Feb 25;375(6583):889-894. doi: 10.1126/science.abg9868. Epub 2022 Feb 24.
Treatment of bacterial infections currently focuses on choosing an antibiotic that matches a pathogen's susceptibility, with less attention paid to the risk that even susceptibility-matched treatments can fail as a result of resistance emerging in response to treatment. Combining whole-genome sequencing of 1113 pre- and posttreatment bacterial isolates with machine-learning analysis of 140,349 urinary tract infections and 7365 wound infections, we found that treatment-induced emergence of resistance could be predicted and minimized at the individual-patient level. Emergence of resistance was common and driven not by de novo resistance evolution but by rapid reinfection with a different strain resistant to the prescribed antibiotic. As most infections are seeded from a patient's own microbiota, these resistance-gaining recurrences can be predicted using the patient's past infection history and minimized by machine learning-personalized antibiotic recommendations, offering a means to reduce the emergence and spread of resistant pathogens.
目前,细菌感染的治疗主要集中在选择与病原体敏感性相匹配的抗生素上,而较少关注即使是敏感性匹配的治疗也可能因治疗引起的耐药性而失败的风险。通过对 1113 个治疗前后细菌分离株进行全基因组测序,并对 140349 例尿路感染和 7365 例伤口感染进行机器学习分析,我们发现可以在个体患者层面预测和最小化治疗诱导的耐药性出现。耐药性的出现很常见,并不是由新的耐药性进化引起的,而是由于对规定抗生素耐药的不同菌株的快速再感染。由于大多数感染是由患者自身的微生物群引发的,因此可以使用患者的既往感染史来预测这些耐药性复发,并通过机器学习的个性化抗生素推荐来最小化它们,从而提供一种减少耐药病原体出现和传播的方法。